Ratios Revealed: Decoding ITeos Therapeutics Inc (ITOS)’s Financial Health

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of ITeos Therapeutics Inc (NASDAQ: ITOS) was $8.24 for the day, down -0.96% from the previous closing price of $8.32. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 0.82 million shares were traded. ITOS stock price reached its highest trading level at $8.59 during the session, while it also had its lowest trading level at $8.22.

Ratios:

Our analysis of ITOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.80 and its Current Ratio is at 14.80. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 13, 2024, initiated with a Overweight rating and assigned the stock a target price of $31.

On May 05, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $37.

On October 08, 2020, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $45.Robert W. Baird initiated its Outperform rating on October 08, 2020, with a $45 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 19 ’24 when Gall Matthew bought 5,000 shares for $7.73 per share. The transaction valued at 38,635 led to the insider holds 65,429 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITOS now has a Market Capitalization of 301039328 and an Enterprise Value of -182142512. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.80 while its Price-to-Book (P/B) ratio in mrq is 0.48. Its current Enterprise Value per Revenue stands at -5.204 whereas that against EBITDA is 1.257.

Stock Price History:

Over the past 52 weeks, ITOS has reached a high of $18.75, while it has fallen to a 52-week low of $7.54. The 50-Day Moving Average of the stock is -12.09%, while the 200-Day Moving Average is calculated to be -36.77%.

Shares Statistics:

ITOS traded an average of 692.31K shares per day over the past three months and 525940 shares per day over the past ten days. A total of 35.84M shares are outstanding, with a floating share count of 30.81M. Insiders hold about 15.67% of the company’s shares, while institutions hold 86.83% stake in the company. Shares short for ITOS as of 1730332800 were 3119292 with a Short Ratio of 4.51, compared to 1727654400 on 4815858. Therefore, it implies a Short% of Shares Outstanding of 3119292 and a Short% of Float of 16.0.

Most Popular